Phase 2 Clinical Trial for Alveolar Soft Part Sarcoma Patients: Testing Atezolizumab, A Study by the NCI
Dear ASPS community, please read the recent update of this clinical trial from September 2020: This is a Phase II clinical study testing the ability of the anti-PD-L1 antibody, Atezolizumab, in treating patients with ASPS that has spread to other parts of the body and cannot be removed by surgery. The FDA granted Breakthrough Therapy Designation […]